Also, treatment of primary human brain microvascular cells and astrocytes with IFN-β upregulated CD73 expression and inhibited transmigration of CD4+ T cells via an in vitro BBB model indicating that the increased expression of CD73 is protective in MS (Niemelä et al., 2008). This evidence concerns the gene CD4 and myeloid sarcoma.